Internal Medicine, Hematology & Oncology · Christiansted, VI
NPI
1255574125
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3018 Orange Grove
Christiansted, VI, 00820
Phone (340) 772-1551
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
21,066 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$9.3M
1,683 prescriptions
Company payments, 2023
$27.5
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth J Delgiacco was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 3,434 times for 23 patients. In total Elizabeth J Delgiacco billed 21,066 services in 72 codes, and Medicare paid $326K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-14.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,434 | 23 | $0.09 | $304 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,804 | 15 | $0.07 | $130 |
| 36415 Venipuncture Blood Collection | Office | 1,465 | 428 | $8.63 | $13K |
| 99214 Office E&M - Established | Office | 1,420 | 391 | $99.30 | $141K |
| 85025 Blood Count | Office | 1,381 | 415 | $7.51 | $10K |
| 96367 Intravenous Infusion, Hydration | Office | 533 | 34 | $22.82 | $12K |
| 96372 Injection Administration | Office | 495 | 46 | $11.35 | $5,618 |
| 99213 Office E&M - Established | Office | 401 | 204 | $59.67 | $24K |
| 96413 Chemotherapy Administration | Office | 345 | 48 | $101.88 | $35K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 321 | 21 | $5.01 | $1,608 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 308 | 38 | $0.58 | $179 |
| 96415 Chemotherapy Administration | Office | 276 | 28 | $22.10 | $6,099 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 174 | 19 | $0.94 | $163 |
| 96375 Injection Administration | Office | 158 | 22 | $10.71 | $1,693 |
| 96365 Intravenous Infusion, Hydration | Office | 154 | 28 | $43.76 | $6,738 |
By year: 2022 $513K for 33,525 services; 2023 $432K for 23,331 services; 2024 $326K for 21,066 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,465 | 428 | $8.63 | $13K |
| 85025 Blood Count | 1,381 | 415 | $7.51 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth J Delgiacco prescribed most often to Medicare patients was Keytruda (Pembrolizumab), with 111 prescriptions and refills. In total Elizabeth J Delgiacco wrote 1,683 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Keytruda Pembrolizumab | 111 | 114 | Under 11 | $1.4M |
| Revlimid Lenalidomide | 89 | 89 | 11 | $1.6M |
| Anastrozole Generic | 85 | 89 | 14 | $1,791 |
| Letrozole Generic | 63 | 73 | 11 | $1,495 |
| Dexamethasone Generic | 52 | 56 | 11 | $831 |
| Procrit Epoetin Alfa | 52 | 52 | Under 11 | $132K |
| Darzalex Daratumumab | 52 | 52 | Under 11 | $596K |
| Prednisone Generic | 40 | 43 | Under 11 | $417 |
| Docetaxel Generic | 38 | 38 | Under 11 | $3,846 |
| Imatinib Mesylate Generic | 35 | 35 | Under 11 | $2,635 |
| Imbruvica Ibrutinib | 32 | 32 | Under 11 | $674K |
| Xarelto Rivaroxaban | 32 | 32 | Under 11 | $23K |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $460K |
| Fosaprepitant Dimeglumine Generic | 30 | 30 | Under 11 | $1,136 |
| Trelstar Triptorelin Pamoate | 30 | 112 | 11 | $101K |
Brand drugs: 824 claims; generic drugs: 859 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Elizabeth J Delgiacco $27.5 ($27.5 in general payments such as food, travel and fees) from 1 company. The largest payer was Rigel Pharmaceuticals, Inc. with $27.5.
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $27.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.